MRAI vs VMD: stock comparison and AI forecast
Marpai, Inc. (MRAI) and Viemed Healthcare, Inc. (VMD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
MRAI Marpai, Inc.
- Price
- $2.77 +965.4% · 6M
- Market Cap
- $74M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
VMD Viemed Healthcare, Inc.
- Price
- $9.13 -0.9% · 6M
- Market Cap
- $348M
- P/E Ratio
- 23.4x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- VMD is 4.7 times larger than MRAI by market capitalization ($348M against $74M).
- Over the last six months MRAI returned +965.4% and VMD -0.9%.
- VMD turns 5.0% of its revenue into net income, against -101.5% for MRAI.
- Both companies share the SEC industry classification Services-Misc Health & Allied Services, NEC.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | MRAI | VMD |
|---|---|---|
| Market Cap | $74M | $348M |
| P/E Ratio | – | 23.41x |
| P/B Ratio | – | 2.32x |
| EPS | $-0.85 | $0.39 |
| Book Value/Share | – | $3.94 |
| Revenue/Share | $0.62 | $8.15 |
| FCF/Share | – | $0.56 |
Profitability & Margins
| Metric | MRAI | VMD |
|---|---|---|
| ROE | – | 10.4% |
| ROA | -178.4% | 7.5% |
| ROIC | 96.7% | 15.0% |
| Gross Margin | 25.9% | 57.4% |
| Operating Margin | -81.8% | 7.8% |
| Net Margin | -101.5% | 5.0% |
| EBT Margin | -101.5% | 7.4% |
| Tax Rate | – | 29.2% |
Financial Health
| Metric | MRAI | VMD |
|---|---|---|
| Current Ratio | 0.38x | 1.25x |
| Quick Ratio | – | 1.16x |
| D/E Ratio | – | 0.37x |
| Financial Leverage | – | 1.38x |
| Interest Coverage | -190.7x | 59.0x |
| Working Capital | -$15M | $12M |
Cash Flow
| Metric | MRAI | VMD |
|---|---|---|
| Operating Cash Flow | -$9M | $54M |
| Free Cash Flow | – | $21M |
| Capital Spending | – | -$33M |
| OCF Growth YoY | – | 11.2% |
| FCF Growth YoY | – | 296.9% |
| FCF/Sales | – | 6.9% |
| CapEx/Sales | – | 10.5% |
Operational Efficiency
| Metric | MRAI | VMD |
|---|---|---|
| Asset Turnover | 1.76x | 1.49x |
| Receivables Turnover | 16.4x | 8.9x |
| Inventory Turnover | – | 29.0x |
| Fixed Assets Turnover | – | 4.1x |
| Days Sales Outstanding | 22 days | 41 days |
| Days Inventory | – | 13 days |
| Payables Period | 171 days | – |
Income Statement
| Metric | MRAI | VMD |
|---|---|---|
| Total Revenue | $17M | $310M |
| Operating Income | -$14M | $24M |
| Net Income | -$17M | $16M |
| R&D Expense | $10K | $2M |
| SG&A Expense | $17M | $140M |
| Cost of Goods Sold | $12M | $132M |
Dividend & Shareholder Information
| Metric | MRAI | VMD |
|---|---|---|
| Shares Outstanding | 27M | 38M |
| Net Income Growth | – | 14.8% |
| EPS Growth | – | 44.4% |
MRAI vs VMD: stock comparison and AI forecast
Which is bigger, MRAI or VMD?
VMD is 4.7 times larger than MRAI by market capitalization ($348M against $74M).
Which stock performed better over the last six months, MRAI or VMD?
Over the last six months MRAI returned +965.4% and VMD -0.9%.
Which one does Intratio's AI model rank higher, MRAI or VMD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.